Incidence and clinical relevance of heparin‐induced antibodies in patients with deep vein thrombosis treated with unfractionated or low‐molecular‐weight heparin
- 29 August 2002
- journal article
- clinical trial
- Published by Wiley in British Journal of Haematology
- Vol. 118 (4) , 1137-1142
Abstract
Summary. The frequency of heparin‐induced thrombocytopenia (HIT) varies between different clinical treatment settings and remains unknown for patients treated with unfractionated (UFH) or low‐molecular‐weight heparin (LMWH) because of deep vein thrombosis. In this multicentre, open‐label study, 1137 patients with deep vein thrombosis were randomly assigned to UFH for 5–7 d, reviparin, a LMWH, for 5–7 d (short‐treated group) or reviparin for 28 d (long‐treated group). Heparin‐platelet factor 4 antibodies (HPF4‐A) were determined on d 5–7 and d 21. Heparin‐induced thrombocytopenia was defined by clinical evaluation. Two patients in the UFH group (incidence: 0·53%, 95% confidence interval (CI): 0·06–1·91) and two patients in the long‐treated LMWH group (incidence: 0·53%, 95% CI: 0·06–1·92) had HIT, while no HIT was observed in the short‐treated LMWH group. Pulmonary embolism developed in one of the HIT‐patients, who had HPF4‐A and was treated with UFH. On d 5–7 the incidence of HPF4‐A was 9·1% in the UFH group, 2·8% in the short‐treated LMWH group and 3·7% in the long‐treated LMWH group, with a significant increase to 20·7% in the UFH group and to 7·5% in the long‐treated LMWH group on d 21. Therefore the incidence of HPF4‐A and heparin‐induced thrombocytopenia was lower in patients treated with LMWH compared with UFH for the same duration of treatment.Keywords
This publication has 17 references indexed in Scilit:
- Effects of a Low-Molecular-Weight Heparin on Thrombus Regression and Recurrent Thromboembolism in Patients with Deep-Vein ThrombosisNew England Journal of Medicine, 2001
- Prevalence of Heparin-Associated Antibodies Without Thrombosis in Patients Undergoing Cardiopulmonary Bypass SurgeryCirculation, 1997
- Heparin‐induced thrombocytopenia and thrombosis: a prospective analysis of the incidence in patients with heart and cerebrovascular diseasesBritish Journal of Haematology, 1997
- Heparin-related thrombosis despite normal platelet counts in vascular surgeryThe American Journal of Surgery, 1997
- Heparin-induced antibodies as a risk factor for thromboembolism and haemorrhage in patients undergoing chronic haemodialysisThe Lancet, 1996
- A Comparison of Low-Molecular-Weight Heparin Administered Primarily at Home with Unfractionated Heparin Administered in the Hospital for Proximal Deep-Vein ThrombosisNew England Journal of Medicine, 1996
- Treatment of Venous Thrombosis with Intravenous Unfractionated Heparin Administered in the Hospital as Compared with Subcutaneous Low-Molecular-Weight Heparin Administered at HomeNew England Journal of Medicine, 1996
- Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated HeparinNew England Journal of Medicine, 1995
- AnnotationBritish Journal of Haematology, 1995
- Heparin‐induced thrombocytopenia: mechanism of interaction of the heparin‐dependent antibody with plateletsBritish Journal of Haematology, 1989